-
Studies suggest growing potential for GLP-1 medications
A growing body of evidence suggests that glucagon-like peptide-1 (GLP-1) medications could become a common approach to improving glucose control in a variety of clinical situations. Richard E. Pratley, MD, and several other researchers presented studies Saturday morning that showed generally favorable results from novel and familiar GLP-1 receptor agonists in type 2 diabetes, type…
-
Hong Kong quality improvement model provides targeted care with results
During Saturday’s ADA Diabetes Care Symposium, Juliana CN Chan, MB, ChB, MD, FRCP, discussed how a research-driven quality improvement initiative in Hong Kong evolved to help reform the delivery of diabetes care in China.
-
Insights into Pancreatic Beta-Cell Function from Type 2 Diabetes GWAS
Anna L. Gloyn, DPhil, previews her presentation “Insights into Pancreatic Beta-Cell Function from Type 2 Diabetes GWAS,” which begins at 4:00 p.m. Saturday in W-2002 (West, Level 2).
-
Renal Effects of GLP-1 Receptor Agonists: From Basic Mechanisms to Clinical Data
Julie A. Lovshin MD, PhD, previews her presentation “Renal Effects of GLP-1 Receptor Agonists: From Basic Mechanisms to Clinical Data,” which begins at 1:45 p.m. Saturday in N-Hall E (North, Exhibition Level).
-
Results from TrialNet, RISE, DECLARE-TIMI 58, and REWIND trials to be presented Sunday
Sunday will feature more highly anticipated study announcements than any other day of the 79th Scientific Sessions. Here’s an ADAMeetingNews.org preview of the the four Sunday sessions featuring major study results.
-
Q&A: Using advanced diabetes technology in older adults
The Centers for Medicare and Medicaid Services approved reimbursement for select continuous glucose monitoring (CGM) devices in 2017, but there are limited data on the use of CGM, insulin pumps, and other advanced diabetes technologies in older adults. Three clinical researchers, including Medha Munshi, MD, will share their insights, experience, and trial results during Sunday’s…
-
Behavioral economics used to improve patient engagement, promote healthy food choices
A panel of experts, including Jeffrey T. Kullgren, MS, MD, MPH, and Anne N. Thorndike, MD, MPH, will discuss ways to improve the effectiveness of diabetes interventions during Sunday’s symposium “Which Benefit Design and Behavioral Economic Interventions Can Be Used to Facilitate Diabetes Prevention?”
-
A mother’s diabetes may affect child’s neurobehaviors and cognitive function
Emerging data suggest that the offspring of mothers who have diabetes during pregnancy are at increased risk of cognitive and neurodevelopmental disorders. These mental effects are in addition to better-known metabolic risks associated with maternal diabetes, according to Anny Xiang, PhD, and Peter Damm, MD.
-
5 More Things about Sunday
Don’t forget to Wear Red Sunday to show your support of the ADA and our mission to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. And it’s not too late to register for Sunday morning’s 5K@ADA run/walk through San Francisco.
-
D2d Study: Vitamin D supplementation does not significantly reduce risk of type 2 diabetes
Among vitamin D-sufficient adults at high risk for type 2 diabetes, vitamin D supplementation at a dose of 4000 IU per day did not significantly lower the risk of diabetes compared to placebo, according to the results of the Vitamin D and Type 2 Diabetes (D2d) Study – A Multicenter Randomized Controlled Trial for Diabetes…